Who Paid My Doc
Vaxchora
Drug Cholera Vaccine
NDC 70460-004-01
General payments
$539,280
Research payments
$314,882
Through program year 2023, $539,280 in general payments and $314,882 in research payments were reported against Vaxchora (Cholera Vaccine).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $87,850 | 25 |
| 2022 | General | $126,875 | 44 |
| 2022 | Research | $11,988 | 9 |
| 2021 | General | $163,488 | 51 |
| 2021 | Research | $20,263 | 11 |
| 2020 | General | $161,067 | 38 |
| 2020 | Research | $282,632 | 42 |
Breakdown
Each share is of general payments naming this product in 2023.
Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2023 where a state was reported.
Records
158 general · 62 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.